Gene: SIAE
Official Full Name: sialic acid acetylesteraseprovided by HGNC
Gene Summary: This gene encodes an enzyme which removes 9-O-acetylation modifications from sialic acids. Mutations in this gene are associated with susceptibility to autoimmune disease 6. Multiple transcript variants encoding different isoforms, found either in the cytosol or in the lysosome, have been found for this gene.[provided by RefSeq, Feb 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21787 | SIAE Knockout cell line (HeLa) | Human | SIAE | 1:3~1:6 | Negative | Online Inquiry |
KO21788 | SIAE Knockout cell line (HCT 116) | Human | SIAE | 1:2~1:4 | Negative | Online Inquiry |
KO21789 | SIAE Knockout cell line (HEK293) | Human | SIAE | 1:3~1:6 | Negative | Online Inquiry |
KO21790 | SIAE Knockout cell line (A549) | Human | SIAE | 1:3~1:4 | Negative | Online Inquiry |
SIAE Gene Knockout Cell Lines are a collection of highly specialized cell lines that have been engineered to contain targeted deletions of the SIAE (Sialic Acid Acetylesterase) gene. This gene plays a crucial role in regulating sialic acid modifications on glycoproteins and is significant in various biological processes, including immune responses and cellular signaling. By understanding the functional consequences of SIAE gene loss, researchers can manipulate these cell lines to explore various cellular pathways and mechanisms in a controlled environment.
The key function of SIAE gene knockout cell lines lies in their ability to mimic specific disease states or physiological conditions relevant to sialidase activity. These cell lines exhibit altered glycosylation patterns, making them valuable tools for studying the implications of sialic acid modulation in cancer progression, autoimmune disorders, and infectious diseases. The mechanism by which these knockouts operate allows researchers to delve into sialic acid's impact on cell adhesion, migration, and immune evasion.
Scientifically, these cell lines hold great importance in both academic research and clinical applications, enabling scientists to investigate the role of SIAE in immune regulation and pathogen-host interactions. They serve as platforms for drug discovery and validation, potentially leading to novel therapeutic strategies targeting diseases associated with sialic acid dysregulation.
What sets SIAE Gene Knockout Cell Lines apart from other genomic editing models is their specificity and reliability. Developed through cutting-edge CRISPR-Cas9 technology, these cell lines ensure precise gene disruption without off-target effects, allowing for reproducible and dependable results. Their robustness means they can be used across a range of experimental setups, including high-throughput screening and functional assays.
For researchers and clinicians, the value of SIAE Gene Knockout Cell Lines stretches beyond basic research; they are critical tools for elucidating complex biological phenomena and developing new therapeutic insights. By investing in these cell lines, users significantly enhance their research capabilities and accelerate the translation of findings into clinical modalities.
With a commitment to advancing biological research, our company leverages extensive expertise in genetic engineering and cell culture technologies to deliver high-quality, reliable products like the SIAE Gene Knockout Cell Lines, empowering researchers to push the boundaries of science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.